5 Ways Pharmacists Can Improve Clinical Trials
Clinical researchers are beginning to ask why pharmacists are not well-represented on clinical drug trial teams. When most people think […]
Clinical researchers are beginning to ask why pharmacists are not well-represented on clinical drug trial teams. When most people think […]
Aggressive generic delay practices are troubling because, unlike patent exclusivity, they do not promote any public interest Increasing the costs
Drugs With No Patents And No Competition: Here’s Why Read Post »
Many factors influence whether physicians prescribe brand name or generic drugs High prices for prescription drugs are the focus of several
Prescribing of Generic Drugs Goes Up When Sales Visits Go Down Read Post »
Pharmaceutical companies have devised powerful strategies to forestall their loss of profits post patent expiration Losing patent protection on a
Using Patent Filings to Model Branded Pharmaceutical Post-Expiration Strategies Read Post »
Identifying the testing phase can be tricky This is a guest post from Nicole Stakleff and Kyle Dolinsky in Pepper
Calculating the Regulatory Review Period for Patent Term Extension Read Post »
Companies developing a new drug product, even if it is not an NCE, should explore ways to increase the likelihood
Patent Term Extension for Drugs not Limited to new Chemical Entities Read Post »
The value of obtaining multiple PTEs on different patents could incentivize innovators to revise their clinical development programs This is
How to Obtain Multiple Patent Term Extensions for a Single Product Read Post »
The total cost of developing, manufacturing, testing, and marketing a generic drug in India costs just 20% to 40% of
Billions are on the table for those who can break out of the mind rubble This is a guest post